Phase I study of PS-341 (bortezomib) with 5-fluorouracil/leucovorin (5-FU/LV) in advanced solid tumors: A California Cancer Consortium study.

被引：0
|
作者：
Iqbal, S
Cole, S
Yang, D
Lara, PN
Gumerlock, PH
Shibata, S
Synold, T
Doroshow, JH
Gandara, D
Lenz, HJ
机构：
[1] Univ So Calif, Los Angeles, CA USA
[2] Univ Calif Davis, Sacramento, CA USA
[3] City Hope Natl Med Ctr, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2057
引用
收藏
页码：141S / 141S
页数：1
相关论文
共 50 条
  • [21] Phase I study of docetaxel (TXT) and 5-fluorouracil (5-FU) with concurrent radiotherapy in patients with advanced esophageal cancer
    Hihara, Jun
    Yoshida, Kazuhiro
    Hamai, Yoichi
    Emi, Manabu
    Yamaguchi, Yoshiyuki
    Wadasaki, Koichi
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2597 - 2603
  • [22] Phase I Trial of Sorafenib in Combination With 5-Fluorouracil/Leucovorin in Advanced Solid Tumors
    Shacham-Shmueli, Einat
    Geva, Ravit
    Figer, Arie
    Bulocinic, Sarah
    Nalbandyan, Karen
    Shpigel, Shulim
    Atsmon, Jacob
    Brendel, Erich
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (05): : 656 - 669
  • [23] A phase Ib study of oxaliplatin in combination with fluorouracil (5FU) and leucovorin (LV) in pediatric patients (pts) with advanced solid tumors
    Gore, L.
    Kuttesch, J.
    Hunger, S. P.
    Herzog, C.
    Narendaren, A.
    Boklan, J.
    Foreman, N. K.
    Ivy, S. P.
    Boucher, N.
    Trippett, T. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma
    Fotios Loupakis
    Gianluca Masi
    Lorenzo Fornaro
    Enrico Vasile
    Giacomo Allegrini
    Eloise Fontana
    Cristina Granetto
    Lisa Salvatore
    Lucia Mentuccia
    Michele Andreuccetti
    Enrico Cortesi
    Marco Merlano
    Stefano Cascinu
    Alfredo Falcone
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 559 - 566
  • [25] Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma
    Loupakis, Fotios
    Masi, Gianluca
    Fornaro, Lorenzo
    Vasile, Enrico
    Allegrini, Giacomo
    Fontana, Eloise
    Granetto, Cristina
    Salvatore, Lisa
    Mentuccia, Lucia
    Andreuccetti, Michele
    Cortesi, Enrico
    Merlano, Marco
    Cascinu, Stefano
    Falcone, Alfredo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 559 - 566
  • [26] A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma
    Gennatas, C.
    Papaxoinis, G.
    Michalaki, V.
    Mouratidou, D.
    Andreadis, Ch.
    Tsavaris, N.
    Pafiti, A.
    JOURNAL OF CHEMOTHERAPY, 2006, 18 (05) : 538 - 544
  • [27] A phase II study of 5-FU (F), leucovorin (LV), etoposide (E) and α-interferon (I) in advanced gastric cancer patients
    Destefanis, M
    Capello, C
    Satolli, MA
    Dalla Mola, A
    Castiglione, F
    Miglietta, L
    Marenco, D
    Porcile, G
    Alabiso, O
    ANNALS OF ONCOLOGY, 1998, 9 : 54 - 55
  • [28] Phase I trial of ZD1839 ('Iressa') in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic colorectal cancer.
    de Bono, JS
    Hammond, LA
    Figueroa, J
    Schwartzberg, L
    Ochoa, L
    Patnaik, A
    Olivo, N
    Schwartz, G
    Smith, L
    Ochs, J
    Rowinsky, EK
    BRITISH JOURNAL OF CANCER, 2002, 86 : S50 - S51
  • [29] Phase I dose-finding study of biweekly oxaliplatin (E) in combination with gemcitabine (G), 5-fluorouracil (5-FU), leucovorin (LV) and irinotecan (G-FLIE) in patients with solid tumors.
    Olszewski, AJ
    Malamud, S
    Grossbard, ML
    Mirzoyev, T
    Dietrich, M
    Thurakal, A
    Rodriguez, T
    Kozuch, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 358S - 358S
  • [30] A bi-weekly schedule of irinotecan (CPT-11) and 5-fluorouracil (5-FU) in advanced colorectal cancer (ACRC): Phase I study.
    Morese, R
    Ricevuto, U
    Cannita, K
    Antonini, CGC
    Lanfiuti, BP
    Trapasso, T
    Porzio, G
    Marchetti, P
    Ficorella, C
    ANNALS OF ONCOLOGY, 2000, 11 : 71 - 71
12345